118
Views
7
CrossRef citations to date
0
Altmetric
Reviews

Molecular insight into the biology and clinical course of hairy cell leukemia utilizing immunoglobulin gene analysis

, , , &
Pages 15-23 | Received 30 Sep 2010, Accepted 02 Oct 2010, Published online: 06 Dec 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tadeusz Robak, Anna Wolska & Pawel Robak. (2015) Potential breakthroughs with investigational drugs for hairy cell leukemia. Expert Opinion on Investigational Drugs 24:11, pages 1419-1431.
Read now

Articles from other publishers (6)

Alfred Ankrah & Mike Sathekge. 2018. PET/CT in Infection and Inflammation. PET/CT in Infection and Inflammation 15 27 .
John C Allen, Fatima Talab & Joseph R Slupsky. (2016) Targeting B-cell receptor signaling in leukemia and lymphoma: how and why?. International Journal of Hematologic Oncology 5:1, pages 37-53.
Crossref
Edouard Cornet, Alain Delmer, Pierre Feugier, Francine Garnache-Ottou, David Ghez, Véronique Leblond, Vincent Levy, Frédéric Maloisel, Daniel Re, Jean-Marc Zini & Xavier Troussard. (2014) Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia. Annals of Hematology 93:12, pages 1977-1983.
Crossref
Mariela Sivina, Robert J. Kreitman, Evgeny Arons, Farhad Ravandi & Jan A. Burger. (2014) The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach. British Journal of Haematology 166:2, pages 177-188.
Crossref
V Maevis, U Mey, G Schmidt-Wolf & I G H Schmidt-Wolf. (2014) Hairy cell leukemia: short review, today’s recommendations and outlook. Blood Cancer Journal 4:2, pages e184-e184.
Crossref
Carsten U. Niemann & Adrian Wiestner. (2013) B-cell receptor signaling as a driver of lymphoma development and evolution. Seminars in Cancer Biology 23:6, pages 410-421.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.